Recombinant Histidine--tRNA ligase (hisS)

What is Histidine-tRNA ligase and what is its fundamental function?

Histidine-tRNA ligase (hisS) is an essential enzyme that catalyzes the aminoacylation reaction, attaching histidine to its corresponding tRNA molecule (tRNA^His). This charged tRNA is crucial for protein biosynthesis, as it delivers histidine to the ribosome during translation. The enzyme belongs to the class IIa aminoacyl-tRNA synthetase family and functions as a homodimer . Histidine-tRNA ligase is notably one of the smallest bacterial aminoacyl-tRNA synthetases, with the Escherichia coli version containing only 424 amino acid residues per monomer, less than half the size of the largest aminoacyl-tRNA synthetases .

What are the key structural domains of Histidine-tRNA ligase?

Histidine-tRNA ligase comprises three distinct domains, each with specific functions:

• N-terminal catalytic domain: Contains a six-stranded antiparallel β-sheet and the three motifs common to all class II aminoacyl-tRNA synthetases. This domain is responsible for the activation of histidine and the aminoacylation reaction .

• C-terminal domain: An α/β domain common to most class IIa synthetases that recognizes and binds the anticodon stem-loop of tRNA^His .

• HisRS-specific insertion domain: A unique α-helical domain inserted into the catalytic domain between motifs II and III. This domain is positioned above the catalytic site and likely clamps onto the acceptor stem of tRNA during aminoacylation .

These structural elements work together to ensure both the specificity and efficiency of the aminoacylation reaction.

What are the unique motifs in Histidine-tRNA ligase for substrate recognition?

Histidine-tRNA ligase contains two specific motifs that are crucial for histidine binding and are highly conserved across all known HisRS enzymes:

• Histidine A (HisA): The consensus sequence RGLDYY (residues 259-264 in Thermus thermophilus)

• Histidine B (HisB): The consensus sequence GGRYDG (residues 285-290 in Thermus thermophilus)

These motifs play essential roles in substrate recognition and catalysis. Upon histidine binding, the HisA motif undergoes a conformational rearrangement that increases hydrogen bonding capabilities and enhances the shape and electrostatic complementarity of the binding pocket. This conformational change optimizes the amino acid binding pocket specificity for histidine, thereby enhancing enzymatic fidelity .

What are the typical kinetic parameters for Histidine-tRNA ligase?

The kinetic parameters of Histidine-tRNA ligase vary somewhat between species but follow similar patterns. For Pseudomonas aeruginosa HisRS, detailed kinetic studies have revealed the following parameters:

How do mutations in the hisS gene affect enzyme function?

Mutations in the hisS gene can significantly alter enzyme kinetics and cellular function. Studies with E. coli hisS mutants have demonstrated various effects:

• Altered substrate affinity: Some mutations (e.g., hisS1520) dramatically reduce the enzyme's affinity for histidine, with K_M values increasing from 1.5 × 10^-4 M in wild-type to 80 × 10^-4 M in the mutant, a 50-fold difference .

• Reduced catalytic activity: Certain mutants (e.g., hisS1520) show greatly diminished synthetase activity (<0.2% of wild-type) when measured by standard assays, while others (e.g., hisS1209, hisS1210) maintain sufficient activity for normal growth .

• Growth rate effects: Some mutants (e.g., hisS1520) exhibit significantly slower growth rates on minimal medium, while others show normal doubling times despite altered enzyme kinetics .

• Impact on histidine operon regulation: Mutations that reduce synthetase activity often lead to derepression of the histidine biosynthetic pathway, suggesting that the charged tRNA^His level serves as a regulatory signal .

What is the mechanism of histidine activation by the enzyme?

Histidine-tRNA ligase catalyzes aminoacylation in a two-step reaction:

• Activation step: The enzyme binds histidine and ATP to form histidyl-adenylate, releasing pyrophosphate.

• Transfer step: The activated histidine is transferred to the 3' end of tRNA^His.

Crystal structure analysis of T. thermophilus HisRS has revealed that the HisRS-specific Arg-259 in the HisA motif interacts directly with the α-phosphate of the adenylate on the opposite side to the conserved motif 2 arginine. This arginine substitutes for the divalent cation observed in other aminoacyl-tRNA synthetases and plays a crucial catalytic role in the mechanism of histidine activation .

The conformational changes upon histidine binding optimize the active site geometry for catalysis, enhancing both specificity and reaction rate.

What are the optimal systems for recombinant expression of Histidine-tRNA ligase?

For recombinant expression of bacterial Histidine-tRNA ligase, Escherichia coli expression systems are most commonly employed due to their efficiency and simplicity. The P. aeruginosa HisRS has been successfully overexpressed in E. coli systems . When designing an expression system, consider the following:

• Expression vector: pET-based vectors with T7 promoters typically yield high expression levels.

• Host strain: BL21(DE3) or its derivatives are often used for their reduced protease activity.

• Affinity tags: Histidine tags are commonly used, which is somewhat ironic given the enzyme's function, but allows simple purification by immobilized metal affinity chromatography (IMAC).

• Expression conditions: Lower temperatures (16-25°C) and longer induction times often improve the solubility and activity of the recombinant enzyme.

The expression construct should include the complete hisS coding region, which in E. coli consists of 424 codons .

What purification strategies yield the highest activity of recombinant Histidine-tRNA ligase?

A multi-step purification approach typically yields the highest activity:

• Initial capture: Affinity chromatography (IMAC for His-tagged protein) or ion exchange chromatography.

• Intermediate purification: Hydrophobic interaction chromatography or a second ion exchange step.

• Polishing: Size exclusion chromatography to remove aggregates and ensure a homogeneous dimeric state.

Critical considerations include:

• Maintaining reducing conditions (e.g., DTT at 1-5 mM) throughout purification to prevent oxidation of cysteine residues .

• Including magnesium ions (7.5 mM MgCl₂) in buffers to stabilize the active site .

• Using protease inhibitors during initial extraction to prevent degradation.

• Avoiding freeze-thaw cycles by aliquoting the purified enzyme before storage.

How should recombinant Histidine-tRNA ligase be stored to maintain activity?

To preserve enzymatic activity, store purified Histidine-tRNA ligase under the following conditions:

• Temperature: -80°C for long-term storage; -20°C for working stocks.

• Buffer composition: 50 mM Tris-HCl (pH 7.5), 100-150 mM NaCl, 1-2 mM DTT, 0.1 mM EDTA, and 50% glycerol.

• Aliquoting: Divide into small aliquots to avoid repeated freeze-thaw cycles.

• Activity preservation: Add bovine serum albumin (BSA, 0.1 mg/mL) as a stabilizing agent.

For applications requiring maximum activity, perform quality control by measuring specific activity before and after storage using aminoacylation assays with radiolabeled histidine .

What methods are available for assaying Histidine-tRNA ligase activity?

Several methods can be used to measure Histidine-tRNA ligase activity, each with specific advantages:

• Filter binding assays: Measure aminoacylation using radiolabeled [¹⁴C] or [³H] histidine. This is a gold standard method with high sensitivity .

  Protocol overview:

  • Reaction mixture: 50 mM Tris-HCl (pH 7.5), 7.5 mM MgCl₂, 2.5 mM ATP, 1 mM DTT, 75 μM [¹⁴C] histidine, and 0.1 μM purified HisRS

  • Vary tRNA^His concentrations (0.03-4.5 μM) for kinetic studies

  • Stop reactions at timed intervals (1-5 min)

  • Collect aminoacylated tRNA on filters and quantify by scintillation counting

• Pyrophosphate exchange assay: Measures the first step of the reaction (formation of histidyl-adenylate) by quantifying the ATP-PP_i exchange rate. This method has been used to determine the K_m values for histidine in both wild-type and mutant enzymes .

• Scintillation proximity assay (SPA): A high-throughput screening method useful for inhibitor discovery .

• Coupled enzyme assays: Measure pyrophosphate release using auxiliary enzymes and spectrophotometric detection.

How can the specificity of Histidine-tRNA ligase be investigated?

To investigate the specificity of Histidine-tRNA ligase, researchers can employ several complementary approaches:

• Comparative aminoacylation: Test the enzyme's ability to charge different tRNA species and measure relative aminoacylation rates.

• Substrate competition assays: Determine the enzyme's discrimination between histidine and structural analogs by measuring competitive inhibition of aminoacylation.

• Codon recognition studies: Analyze the binding of histidyl-tRNA to ribosomes in the presence of different codons. Previous studies have shown that CAU and CAC triplets stimulate ribosome binding of histidyl-tRNA .

• Site-directed mutagenesis: Modify the HisA (RGLDYY) and HisB (GGRYDG) motifs to understand their contribution to specificity .

• Structural studies: Use X-ray crystallography to visualize the enzyme in complex with different substrates, as has been done with T. thermophilus HisRS .

What approaches are recommended for studying Histidine-tRNA ligase inhibitors?

A systematic approach to studying Histidine-tRNA ligase inhibitors includes:

• Primary screening: Use high-throughput assays such as SPA to identify potential inhibitors from compound libraries. This approach has successfully identified inhibitors of P. aeruginosa HisRS from natural products and synthetic compounds .

• Inhibition characterization: Determine IC₅₀ values using dose-response curves. For P. aeruginosa HisRS, compounds BT02C02, BT02D04, BT08E04, and BT09C11 showed IC₅₀ values of 4.4, 9.7, 14.1, and 11.3 μM, respectively .

• Mechanism of inhibition: Use kinetic studies to determine if inhibition is competitive, non-competitive, or uncompetitive with respect to each substrate.

• Antimicrobial activity: Test minimum inhibitory concentration (MIC) against pathogenic bacteria to assess broad-spectrum activity .

• Time-kill studies: Determine if inhibitors are bacteriostatic or bactericidal. The inhibitors identified for P. aeruginosa HisRS demonstrated bacteriostatic modes of inhibition .

• Selectivity assessment: Compare inhibition of bacterial versus human histidyl-tRNA synthetases to evaluate potential for developing selective antibiotics.

How does the sequence of Histidine-tRNA ligase compare across species?

Histidine-tRNA ligase sequences show variable conservation patterns across species:

• Bacterial conservation: When comparing HisRS from P. aeruginosa with those from E. coli, S. aureus, or T. thermophilus, sequence similarity ranges from 55% to 73% .

• Bacterial vs. human: P. aeruginosa HisRS shares only 30% sequence similarity with human cytosolic HisRS (hcHisRS) and 31% with human mitochondrial HisRS (hmHisRS) .

• Conserved regions: The HisA (RGLDYY) and HisB (GGRYDG) motifs are highly conserved across all known HisRS enzymes .

• Variable regions: While the histidine binding site shows strict conservation, the ATP binding pocket amino acids are more variable, though the four arginine residues that interact with ATP phosphates are completely conserved in bacterial HisRS enzymes .

This sequence divergence, particularly between bacterial and human enzymes, provides a basis for developing selective inhibitors as potential antibiotics.

What is known about the tRNA recognition elements for Histidine-tRNA ligase?

Histidine-tRNA ligase recognizes tRNA^His through several specific elements:

• Anticodon recognition: The C-terminal domain of HisRS interacts with the anticodon stem-loop of tRNA^His. The enzyme recognizes the GUG anticodon that corresponds to histidine codons (CAU and CAC) .

• Acceptor stem interaction: The HisRS-specific insertion domain is positioned to interact with the acceptor stem of tRNA^His during aminoacylation .

• tRNA species recognition: Studies with hisR mutants (which affect tRNA^His) show that changes in tRNA structure can influence aminoacylation efficiency. These mutants exhibit approximately 55% of the normal level of histidine-specific tRNA acceptor activity .

• Codon-dependent binding: Experimental evidence indicates that CAU and CAC triplets stimulate ribosome binding of histidyl-tRNA to the same extent for both wild-type and mutant tRNA species, suggesting conserved anticodon recognition mechanisms .

How do regulatory mutations in the histidine operon affect Histidine-tRNA ligase function?

Regulatory mutations in the histidine operon can affect Histidine-tRNA ligase function through several mechanisms:

How can Histidine-tRNA ligase be used as a target for antimicrobial development?

Histidine-tRNA ligase presents several advantageous characteristics as an antimicrobial target:

• Essential function: As a key enzyme in protein synthesis, inhibition leads to growth arrest or cell death.

• Structural differences: The limited sequence similarity between bacterial and human HisRS (approximately 30%) provides a basis for selective inhibition.

• Screening feasibility: Robust high-throughput assays have been developed, facilitating the screening of compound libraries. Using SPA technology, researchers have screened 1690 natural and synthetic compounds against P. aeruginosa HisRS .

• Identified inhibitors: Compounds with IC₅₀ values in the low micromolar range (4.4-14.1 μM) have been identified, demonstrating the feasibility of targeting this enzyme .

• Broad-spectrum potential: Inhibitors of P. aeruginosa HisRS have shown activity against multiple pathogenic bacteria, indicating the potential for broad-spectrum antibiotics .

• Mode of action: Time-kill studies indicate a bacteriostatic mode of inhibition for the identified compounds, providing insights into their mechanism of action .

What are the challenges in resolving contradictory experimental data related to Histidine-tRNA ligase?

Researchers face several challenges when resolving contradictory data:

• Enzyme source variations: HisRS from different bacterial species can exhibit different kinetic parameters and inhibitor sensitivities despite sequence similarities of 55-73% .

• Assay methodology differences: Results from filter binding assays, pyrophosphate exchange assays, and other methods may not be directly comparable due to differences in what aspect of the reaction they measure .

• Mutant characterization: Some hisS mutants show normal growth rates despite significantly altered enzyme kinetics, suggesting compensatory mechanisms that may complicate interpretation .

• tRNA complexity: Some studies suggest the possibility of multiple tRNA^His species with similar structures and anticodons, making their separation and individual characterization challenging .

• Structural ambiguities: Despite crystallographic studies, some aspects of the catalytic mechanism remain unclear, particularly the roles of specific residues in substrate binding and catalysis .

To resolve these contradictions, researchers should:

• Use multiple complementary assay methods

• Carefully control experimental conditions

• Perform comparative studies across species

• Combine biochemical, genetic, and structural approaches

• Consider the physiological context of in vitro findings

What future research directions are most promising for Histidine-tRNA ligase studies?

Several promising research directions for Histidine-tRNA ligase include:

• Structure-based drug design: Utilizing the crystal structures of bacterial HisRS in complex with substrates and inhibitors to design more potent and selective antimicrobial compounds .

• Mechanism-based inhibitors: Developing transition-state analogs that mimic the histidyl-adenylate intermediate formed during the activation step .

• Synthetic biology applications: Engineering HisRS variants with altered specificity for use in expanding the genetic code with non-canonical amino acids.

• Systems biology integration: Understanding the role of HisRS in the broader context of cellular metabolism and stress responses, particularly how charged tRNA^His levels influence gene expression.

• Evolutionary studies: Investigating the evolutionary relationships between HisRS enzymes across domains of life, as they appear to have a different progenitor compared to other aminoacyl-tRNA synthetases .

• Combinatorial approaches: Exploring synergistic effects between HisRS inhibitors and other antibiotics to overcome resistance mechanisms and enhance therapeutic efficacy.

• Structural dynamics: Using advanced techniques like cryo-electron microscopy to visualize the complete catalytic cycle, including transient conformational states during tRNA charging.

What are common issues in recombinant Histidine-tRNA ligase expression and how can they be resolved?

Researchers commonly encounter several issues when expressing recombinant Histidine-tRNA ligase:

• Poor solubility: HisRS may form inclusion bodies, particularly at high expression levels.
  Solution: Lower induction temperature (16-18°C), reduce IPTG concentration, use solubility-enhancing fusion tags, or co-express with chaperones.

• Low activity: The recombinant enzyme may show reduced activity compared to native enzyme.
  Solution: Ensure proper folding by optimizing purification conditions, include essential cofactors (Mg²⁺), verify the absence of inhibitory contaminants, and test different buffer compositions.

• Proteolytic degradation: HisRS may be susceptible to proteolysis during expression or purification.
  Solution: Use protease-deficient host strains, include protease inhibitors during lysis, minimize handling time, and maintain low temperatures during purification.

• Dimer stability issues: As HisRS functions as a homodimer, disruption of dimer formation affects activity.
  Solution: Include stabilizing agents in buffers, avoid harsh purification conditions, and verify the dimeric state by size exclusion chromatography.

• Contaminating aminoacyl-tRNA synthetase activities: Host-derived synthetases may interfere with activity assays.
  Solution: Design highly specific assays, use stringent purification protocols, and consider using affinity tags positioned to avoid interference with active sites.

How can researchers validate the quality of purified recombinant Histidine-tRNA ligase?

A comprehensive quality control protocol for purified recombinant Histidine-tRNA ligase should include:

• Purity assessment:

  • SDS-PAGE: >95% homogeneity

  • Mass spectrometry: Verify correct molecular weight and detect potential modifications

• Activity assays:

  • Specific activity determination using standard aminoacylation assay

  • Kinetic parameter measurement (K_M, k_cat) for comparison with literature values

  • Substrate specificity confirmation

• Structural integrity:

  • Size exclusion chromatography to verify dimeric state

  • Circular dichroism to assess secondary structure content

  • Thermal shift assay to evaluate stability

• Functional tests:

  • ATP-PPi exchange assay to verify adenylate formation

  • tRNA binding assays to confirm interaction with tRNA^His

  • Inhibition studies with known inhibitors as positive controls

• Storage stability:

  • Activity retention after freeze-thaw cycles

  • Long-term stability at different storage conditions

These validation steps ensure that the recombinant enzyme is suitable for downstream applications in research or drug discovery.

What statistical considerations are important when analyzing Histidine-tRNA ligase inhibition data?

When analyzing inhibition data for Histidine-tRNA ligase, researchers should consider several statistical aspects:

• Dose-response curve analysis:

  • Use appropriate curve-fitting models (e.g., four-parameter logistic regression)

  • Report both IC₅₀ values and Hill slopes

  • Include 95% confidence intervals for all parameters

• Assay quality metrics:

  • Calculate Z' factor to assess assay robustness

  • Include positive and negative controls in all experiments

  • Report signal-to-background ratios and signal-to-noise ratios

• Mechanism of inhibition determination:

  • Use global fitting of multiple datasets at varying substrate concentrations

  • Apply appropriate models (competitive, non-competitive, uncompetitive)

  • Perform statistical comparison of different models

• Reproducibility assessment:

  • Conduct at least three independent experiments

  • Report both intra-assay and inter-assay variability

  • Use power analysis to determine adequate sample sizes

• Selectivity analysis:

  • Compare inhibition across multiple aminoacyl-tRNA synthetases

  • Calculate selectivity indices with appropriate error propagation

  • Use correlation analysis to identify structure-activity relationships

• Time-dependent inhibition:

  • Apply appropriate kinetic models for time-dependent inhibition

  • Distinguish between rapid reversible and slow-binding inhibition

  • Determine residence time for inhibitors when applicable